New patent for Glaxo Grp drug ADVAIR HFA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ADVAIR+HFA
Annual Drug Patent Expirations for ADVAIR+HFA

Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug.

ADVAIR HFA drug price trends.

Drug patent litigation for ADVAIR HFA.

The generic ingredient in ADVAIR HFA is fluticasone propionate; salmeterol xinafoate. Three suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top